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Aims To quantify left ventricular (LV) dyssynchrony in patients with left bundle branch block (LBBB) and in patients after myo-
cardial infarction (MI) applying an accelerated three-dimensional (3D) tagging cardiac magnetic resonance (CMR) tech-
nique, and to combine dyssynchrony information with viability data obtained by late gadolinium enhancement (LGE) CMR.
Methods
and results
Thirty-two patients (59+ 11 years) after first MI (PatsMI), 10 patients (63+10 years) with LBBB (ejection fraction
, 40%; PatsLBBB,40), 13 patients (63+11) with LBBB (ejection fraction  40%; PatsLBBB40), and 15 healthy controls
(53+10 years) underwent 3D tagging CMR and LGE imaging at 1.5 T. As a measure of mechanical LV dyssynchrony,
the standard deviation of Tmax over the LV, the circumferential uniformity ratio estimate (CURE) index, and a
segmental-based circumferential systolic dyssynchrony index (SDI) were calculated. All three parameters detected
significantly increased circumferential dyssynchrony in patients compared with controls. The CURE and SDI
showed a good correlation (r ¼ 0.93, P, 0.0001) and detected most severe dyssynchrony in PatsLBBB,40
(P, 0.001 vs. controls, P, 0.005 vs. PatsMI). Systolic dyssynchrony index additionally allowed integration of localized
viability information to yield SDIviable which was highest in PatsLBBB,40.
Conclusion Dyssynchrony patterns in the LV can be quantified globally and regionally by 3D tagging CMR. Combination of via-
bility and dyssynchrony information allows for a comprehensive dyssynchrony quantification in patients with LBBB or
post-MI. Future studies are required to test the value of the method to predict responsiveness to resynchronization.
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Introduction
Conduction disturbances as well as ischaemia or scar in the left
ventricular (LV) myocardium have been shown in animals and
humans to cause dyssynchrony and intraventricular unloading
phenomena.1–4 Congestive heart failure patients with features
of dyssynchrony are therefore benefiting from cardiac resynchroni-
zation therapy (CRT). Cardiac resynchronization therapy has
proved successful in large patient populations, but 20–30% of
patients do not appear to respond to CRT5 applying current
patient selection criteria which mainly consider symptoms, global
LV ejection fraction (LVEF), and QRS duration.6 In addition,
more sophisticated approaches using echocardiography to quantify
LV dyssynchrony yielded contradictive results.7–9 Therefore, a
better understanding of the mechanisms involved in the various
forms of intraventricular dyssynchrony is needed.
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Cardiac magnetic resonance (CMR) offers the possibility to
acquire motion-encoded data sets with high temporal resolution
using sophisticated tagging techniques, which can differentiate
local tissue deformation from bulk cardiac motion or tether-
ing.10–12 While conventional, two-dimensional techniques are
limited in practical use by long scan times and slice registration pro-
blems, a novel method was recently introduced,13 which allows
measuring three-dimensional (3D), tagged volumes covering the
entire LV in less than 2 min examination time. Novel post-
processing algorithms such as harmonic phase (HARP) analysis14
and its modifications15 allow 3D strain maps to be analysed in
very short times. And finally, CMR can provide accurate high-
resolution viability information in the entire LV.16,17
A large variety of different mechanical18,19 and temporal3,11
CMR tagging parameters has been suggested to describe dyssyn-
chrony and several parameters have been validated in animal
models.12 A most promising parameter, the circumferential uni-
formity ratio estimate (CURE)12,18,20 (also called TUS: temporal
uniformity of strain), readily predicted the responsiveness to
CRT in dog experiments. However, this approach utilizing the
CURE index is hampered by the fact that dyssynchrony is
lumped into one value (1 ¼ perfect synchrony; 0 ¼ complete
dyssynchrony), thus, the information of location of dyssynchrony
in the LV is no longer available. Consequently, the presence of
dyssynchrony cannot readily be linked to the presence and
distribution patterns of scar in the LV, which has been shown to
be crucial for the prediction of CRT success.21
Accordingly, the aims of this study were: (i) to transfer the
tagging approach that was proved successful in canine experiments
into humans with both preserved and reduced LV function and to
further characterize the dyssynchrony patterns caused by either
left bundle branch block (LBBB) or ischaemic heart disease with
scarring; (ii) to improve the assessment of dyssynchrony allowing
for the integration of viability information into the 3D data sets;
and (iii) finally in order to be clinically applicable, to assess the
inter-study, the inter-observer, and the intra-observer reproduci-
bility of these measurements.
Methods
Study population
The study protocol was approved by the local Ethics Committee and
all subjects gave written informed consent before study participation.
Between October 2006 and January 2009, 35 patients with LBBB
[without a history of coronary artery disease (CAD) and myocardial
infarction (MI) or valve disease; PatsLBBB] were screened for this
study. Eight patients with atrial fibrillation or an implanted pacemaker
were excluded. Four patients refused participation in the current study.
In order to describe and quantify LV dyssynchrony in PatsLBBB with
preserved and reduced LV function, the remaining 23 PatsLBBB were
divided into a group with reduced LVEF (10 PatsLBBB,40 with an ejec-
tion fraction , 40%) and preserved LVEF (13 PatsLBBB40 with an ejec-
tion fraction  40%). All patients with LBBB and reduced function
(PatsLBBB,40) had an invasive coronary angiography to exclude CAD
(within 1 year of the CMR study) characterizing them as dilative cardi-
omyopathy patients. To study the dyssynchrony pattern in ischaemic
heart disease, an additional 32 patients were examined between
November 2006 and November 2008 by CMR 9.6+8 days after
their first MI (PatsMI).
In LBBB, the lateral wall typically exhibits a delayed contraction,
thereby causing a stretching of the septum in early diastole. A similar
pattern of post-systolic stretching of the antero-septal wall is observed
in patients after antero-septal MI.2 Therefore, dyssynchrony patterns
were specifically compared between LBBB and patients with antero-
septal MI to study the effect of integration of viability information in
the overall assessment and quantification of LV dyssynchrony. Finally,
between April 2007 and February 2008, 15 age-matched healthy vol-
unteers (without a history or symptoms of cardiovascular disease)
were recruited from a general practitioner and served as the control
group (Controls). Exclusion criteria for study participation were contra-
indications to CMR (typically incompatible metallic implants, claustro-
phobia). Seventy-one subjects of this study cohort successfully
completed the CMR scans and 70 were included in the final analysis
(drop-out: one inadequate tagging analysis). More detailed demographic
and cardiac characteristics of each study group are listed in Table 1.
Data acquisition
The complete imaging protocol is shown schematically in Figure 1. All
measurements were performed on a 1.5 T MRI scanner (Achieva,
Philips Healthcare, Best, The Netherlands). After acquiring survey
images and calibration data, short-axis images covering the entire LV
were acquired using a steady-state free precession (SSFP) sequence
(cardiac phases¼ 20, temporal resolution ¼ 45 ms, slice thickness ¼
8 mm, 13–16 contiguous slices during repetitive breath-holds) to
assess global LV function. An additional SSFP measurement with higher
temporal resolution (cardiac phases¼ 50, temporal resolution ¼
17.6 ms, slice thickness ¼ 8 mm) was performed through the aortic
valve to determine timing of aortic valve closure (AVC).
For 3D tagging data, a novel, accelerated acquisition scheme with
Complementary spatial modulation of magnetization was applied13
requiring three breath-holds of 18 RR intervals duration each to
cover the entire LV. Complementary Spatial Modulation of Magnetiza-
tion acquisition provides a longer tag persistence into diastole,
increases signal-to-noise ratio, is available on most MR machine
types and can be modified to the 3D approach with minor changes.
For read-out, a modified hybrid multi-shot, segmented echo-planar
sequence was employed (field-of-view ¼ 108  108  108 mm3,
voxel size per encoding direction ¼ 3.9  7.7  7.7 mm3, echo
time ¼ 3.3 ms, tag distance ¼ 7 mm). Depending on the heart rate,
19–25 time frames were recorded with a temporal resolution of
27–37 ms and a final flip angle of 18–258. To allow for tagging data
registration, acquisition of the second and third data set was only
started, if the diaphragm position was within a pre-defined window
of 15 mm of the first breath-hold as measured by a navigator
echo.22 Any difference within this 15 mm window was additionally cor-
rected for.
Late gadolinium-enhanced short-axis images covering the entire LV
were additionally acquired in all PatsMI 15 min after administration of a
bolus of 0.25 mmol/kg body weight of Gadobutrolum (Gadovist,
Bayer-Schering Pharma, Germany) using an inversion recovery seg-
mented gradient echo sequence with inversion time set to null
normal myocardium (field-of-view ¼ 350  350 mm2, pixel size ¼
1.5  1.5 mm2, repetition time ¼ 7.4 ms, echo time ¼ 4.4 ms, slice
thickness ¼ 8 mm, no slice gap).
Data analysis
The 3D tagging data were post-processed with HARP14,15 using an
in-house software tool extended for the analysis of 3D tagging data.
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Eight to 11 short-axis mid-wall contours with a spacing of about 58
around the circumference were defined on slices covering the entire
LV. The contours were subsequently HARP tracked14,15 in 3D
space through all time frames using peak combination.15 The spatial
resolution resulting from the 3D bandpass filtering in k-space was
9  9  9 mm3, characterizing the spatial blurring of the final displace-
ment data. Mid-wall circumferential shortening (csh(t), in %) was
defined as the length change of a contour at time t relative to the orig-
inal length at end-diastole (first heart phase). For a detailed analysis of
csh(t) in 48–66 segments of each LV, each mid-wall contour was
divided into sectors of 608 starting at the anterior epicardial junction
of the right and the left ventricles on the equatorial level and num-
bered consecutively from S1 to S6 in clockwise direction as viewed
from the apex. For the segment-wise calculation of the shortening pro-
files, data were resampled at 10 cardiac levels in order to equalize the
number of slices and thus the number of LV segments in all subjects.
While the spatial resolution of the tagging approach results in a
voxel size of 0.27 g, the segment mass is 2.0 g (average LV mass
of 115 g divided by 60 segments).
The time to maximum csh, Tmax, was automatically determined for
each segment. To eliminate unreliable values of Tmax due to akinesia
or tracking artefacts, segments in which Tmax was detected in the
first three or in the last acquired time frame were inspected by an
observer and corrected manually if necessary.23 As a measure of
mechanical LV dyssynchrony, the standard deviation (SD) of Tmax
over the LV was calculated20 as well as the CURE index (details are
given in Appendix and by Leclercq et al.18).
In order to obtain both, localized information about regional dyssyn-
chronous motion and a global dyssynchrony estimate for the entire LV,
a new parameter, the systolic dyssynchrony index (SDI), was calculated
as described in Appendix. Since the SDI is sensitive for heterogeneous
contractions towards the end of systole, high values will recognize late
contracting segments, which would benefit from early pacing.
It was assumed that sectors with altered contraction and . 50%
scar would not recover contraction even when perfectly synchronized.
These sectors were therefore excluded from SDI calculation yielding a
viability-corrected dyssynchrony parameter, i.e. SDIviable.
Reproducibility
In order to assess inter- and intra-observer reproducibility, data analy-
sis was performed in a blinded fashion 2 months after the original
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Table 1 Demographics of study population






n 15 13 10 32
Male, n (%) 11 (73%) 6 (46%) 6 (60%) 27 (84%) ns
Age (years) 53+10 63+11 63+10 59+11 ns
BMI (kg/m2) 24.9+2.3 27.7+7.1 25.0+3.3 26.9+3.6 ns
Heart rate (b.p.m.) 68+12 65+8 79+17 73+17 ns
QRS width (ms) — 143+12* 149+16// 92+14 ,0.0001 ,0.0001*,//
CAD-IRA: LAD, n (%) — — — 27 (84%) —
CAD-IRA: RCA/LCX, n (%) — — — 5 (16%) —
LV-scar (% LV mass) — — — 25.5+10.1 —
LV-EDV (mL) 136+36 145+48 177+44 149+50 ns
LV-ESV (mL) 53+13# 70+30& 128+41 96+39 ,0.0001 ,0.001#,& ,0.001#
LVEF (%) 60+48 53+7& 28+9+ 37+10 ,0.0001 ,0.0018,& ,0.058,&,+
CAD-IRA, infarct-related artery in coronary artery disease patients; LAD, left anterior descending coronary artery; RCA/LCX, right and/or left circumflex coronary artery; EDV,
end-diastolic volume; ESV, end-systolic volume; LVEF, left ventricular ejection fraction. P-values for group-wise comparisons (equal to six possible comparisons) are Bonferroni
corrected.
Figure 1 Imaging protocol. SA, short-axis cardiac views; LA, long-axis cardiac views. For inter-study reproducibility assessment, a second 3D
tagging data set was acquired in five controls, five left bundle branch block patients, and five myocardial infarction patients. Viability imaging was
only performed in MI patients (dashed boxes).
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analysis in randomly chosen patients (five PatsMI and five patients with
LBBB) by the original observer (R.M.). An additional observer (A.K.R.)
independently and blindly analysed the data using the same images in
order to assess inter-observer reproducibility. Both readers had
4 years of experience with MR imaging methods.
For the assessment of inter-study reproducibility, the standard 3D
tagging acquisition was performed twice in 15 randomly chosen sub-
jects (five Controls, five PatsMI, and five patients with LBBB). Reprodu-
cibility was calculated for CURE, SDI, and Tmax SD.
Statistics
Statistical analysis was performed by using the SPSS software package
release 15.0.1 (Chicago, IL, USA). Mean values+ SD were calculated
for all groups. The paired Student’s t-test or Wilcoxon test and inde-
pendent samples t-test or Mann–Whitney test were used to test for
differences within and between groups. All tests were two-tailed. The
Kolmogorov–Smirnov test was used to test for normality. The
results between the four study groups (Tables 1 and 2; Figure 2)
were compared with an analysis of variance followed by Bonferroni
post hoc testing considering six comparisons per parameter (InStat,
3.01, GraphPad Software Inc., San Diego, CA, USA). P-values less
than 0.05 were considered statistically significant. Inter-study, inter-
observer, and intra-observer reproducibility was evaluated by
means of Bland–Altmann plots.24 Linear regression analyses and
partial correlation test by Pearson’s method were done to assess
relations.
The study was powered for the CURE index determined by 3D
tagging CMR. We assumed from a previous study20 a difference in
CURE of 0.3 between controls and subjects with LBBB assessed by
CMR. Considering a SD of 0.1, a sample size of n ¼ 3 (a ¼ 0.05;
power 90%) would be needed. Assuming a smaller difference in
CURE of 0.2 with a SD of 0.1 between controls and patients after
MI, a sample size of n ¼ 6 (a ¼ 0.05; power 90%) would be needed.
Larger patient groups were recruited to account for possible drop-
outs and a potentially higher variability of the SDI parameter, which
was not known a priori. Owing to this lack of information, the
sample size for the inter-study reproducibility assessment was arbitra-
rily set to 15 subjects. As this sample size is rather small, the 95% con-
fidence intervals for the limits of agreement are also presented. For
more robust calculations of sample sizes, e.g. for large clinical trials,




Demographics and cardiac characteristics of each study group are
given in Table 1. The PatsMI group consisted of 32 patients, 18
(56%) of them with one-vessel disease, 9 (28%) with two-vessel
disease, and 5 (16%) with three-vessel disease. The infarct-related
artery was the left anterior descending coronary artery in 27 (84%)
patients, the right coronary artery in three (9%) patients, and the
left circumflex artery in two (7%) patients. Scar mass in the
32 patients was 25.5+ 10.1% of the total LV mass.
Dyssynchrony in Controls, PatsLBBB,
and PatsMI
Global LVEF was lowest in the PatsLBBB,40 with 28+ 9%, i.e. in the
patients with dilative cardiomyopathy (P, 0.001 vs. Controls), fol-
lowed by the PatsMI with 37+10% (P, 0.05 vs. Controls), while
in PatsLBBB40 LVEF was only slightly reduced to 53+7% (ns vs.
Controls, Table 1 and Figure 2). This pattern of reduced LV function
is paralleled by the intraventricular circumferential dyssynchrony as
assessed by the CURE index (lowest CURE values in PatsLBBB,40)
as shown in Figure 2. The proposed SDI shows a similar pattern
with highest dyssynchrony in PatsLBBB,40. The variance of Tmax
over all LV segments calculated by the SD was significantly
greater in PatsLBBB,40 and PatsMI (P, 0.05) compared with con-
trols. In accordance with LVEF results, significantly reduced mean
csh(AVC) over the entire LV could be detected in both PatsLBBB,40
and PatsMI compared with Controls (P, 0.05; Figure 2). Tmax mean
(time to peak csh) was similar in Controls and PatsMI, but was
increased in the patients with LBBB (P, 0.05, Figure 2).
The correlation between the CURE and the SDI parameter was
high (r ¼ 2 0.93; P, 0.0001, Figure 3). The partial correlation coef-
ficients were 20.69, 20.96, 20.95, and 20.87 for Controls,
PatsLBBB40, PatsLBBB,40, PatsMI, respectively. The CURE–SDI
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Table 2 Dyssynchrony and left ventricular function parameters
Controls PatsLBBB40% PatsLBBB<40% PatsMI
n 15 13 10 32
CURE 0.98+0.01 0.92+0.06 0.79+0.15 0.90+0.06
SDI 0.26+0.07 0.55+0.32 1.38+1.30 0.70+0.26
SDIviable 0.26+0.07 0.55+0.32 1.38+1.30 0.46+0.18
Tmax mean (ms) 336+37 391+30 406+49 349+34
Tmax SD (ms) 47+9 73+17 102+36 79+11
LVEF (%) 60+4 53+7 28+9 37+10
csh(AVC) mean (%) 17.4+2.2 15.5+2.8 10.4+3.8 11.1+3.0
Tracking error (%) 5+2 9+4 8+6 7+3
For statistical comparisons, see Figure 2. In PatsMI the difference between SDI and SDIviable was significant (paired t-test, P, 0.0001). SDIviable in PatsLBBB,40 was significantly higher
than in Controls and PatsMI (P, 0.0001) and also higher than in PatsLBBB40 (P, 0.01, all P-values Bonferroni corrected for six comparisons). Tracking error of tagging data
analysis, which indicates data quality, showed no significant differences between groups. One patient with LBBB was excluded from the analysis due to a tracking error in 26% of all
tagging points.
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relationship can also be described by the formula: y ¼ 11.6x2
225.1x+ 13.8 (data not shown), which yields an r-value of 20.97
(P, 0.0001). Both formulas demonstrate an inverse relation
between the two parameters; however, the number of data points
(as shown in Figure 3) appears too small to definitely support a
specific type of correlation. Moreover, LV scar mass and CURE cor-
related similarly as LV scar mass and SDI (Figure 4) in PatsMI.
QRS duration showed a weak inverse correlation with LVEF in
patients (PatsLBBB and PatsMI) with reduced EF, i.e. below 40%
(r ¼ 0.41, P, 0.03, n ¼ 29). In this population, QRS duration
was positively correlated with SDIviable, (r ¼ 0.59, P, 0.001), but
did not correlate with SDI (P ¼ 0.5) or CURE (P ¼ 0.11).
Results of one representative subject out of each study group
(Controls, PatsLBBB, and PatsMI) are given in Figure 5. A patient
after antero-septal infarction is shown to demonstrate the simi-
larity with the LBBB dyssynchrony pattern. Both patients show
increased SDI values (0.71 and 1.26, respectively) compared with
the control (0.27). In the patient after MI, the infarcted segments
show severely reduced (or absent) shortening during systole
(Figure 5G). After AVC post-systolic shortening (equal to elastic
recoil) of the infarcted segments begins immediately with relax-
ation of the non-infarcted (lateral) segments. The patient with
LBBB shows a similar pattern with the septum (segment S6 in
Figure 5D) being even lengthened, i.e. stretched during late
systole due to simultaneous contractions in the lateral wall. As in
the MI patient, the septum of the LBBB patient begins to shorten
in early diastole exactly at the time point when contraction in
the lateral wall (segments S2–S4 in Figure 5D) terminates at
AVC. Although in the MI patient this post-systolic shortening in
the transmural scar region is reflecting an elastic recoil,2 we may
assume that this shortening in the septum of LBBB patients in
early diastole is caused by an elastic recoil of viable myocardium.
In Figure 6, the Controls, the PatsLBBB40, and nine PatsMI with a
medium-sized antero-septal infarction (scar mass 15–25% of LV
mass) were averaged for the SDI parameter and are represented
in the bull’s eye plots. This figure shows a similar dyssynchrony
pattern within the LV for PatsLBBB and PatsMI in agreement with
the examples of Figure 5.
Incorporation of viability information
into dyssynchrony assessment
While the dyssynchrony pattern for PatsLBBB and PatsMI with
antero-septal MI was similar (example in Figure 5 and averaged
bull’s eye plots in Figure 6), the expected maximum improvement
in shortening with CRT in an individual segment would change, if
Figure 2 Dyssynchrony and left ventricular (global) mechanical parameters are shown in the top and bottom row, respectively, for controls,
left bundle branch block patients, and myocardial infarction patients. All values are given as mean+ SD. Horizontal brackets indicate significant
differences (for P, 0.05 with Bonferroni-correction for six comparisons). Overall P-values were , 0.0001 for all parameters. P-values , 0.05
for individual comparisons are not further differentiated for clarity. *P , 0.005 vs. Controls and PatsLBBB,40;
#P , 0.005 vs. Controls and
PatsLBBB40;
&P , 0.01 vs. PatsMI and PatsLBBB40
kP  0.001 vs. Controls and PatsLBBB40; **P , 0.005 vs. Controls and PatsMI.
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one considers the viability information as represented in the bull’s
eye plot in Figure 5L. Consequently, segments with  50% trans-
murality of scar were excluded for the SDI calculation yielding
SDIviable. In the MI patient in Figure 5, the resulting SDIviable was
0.33, which is close to that of 0.27 in the control, i.e. within the
range of normal (95% confidence interval of 0.12–0.40). For com-
parison, the SDIviable of the LBBB patient was 1.26 indicating a
potential gain of resynchronization. Figure 2 demonstrates that
the LBBB patients with reduced EF showed the highest degree of
dyssynchrony as measured with CURE, SDI, or Tmax SD.
However, the SDI, in contrary to CURE and Tmax SD, keeps the
local information and thus, scared segments can be subtracted
from this dyssynchrony measurement. Consequently, in PatsMI
SDI of 0.70+ 0.26 was significantly reduced to SDIviable of
0.46+0.18 (P, 0.0001; paired t-test).
Reproducibility of results and method
performance
As demonstrated in Figure 7, the inter-study, inter- and
intra-observer reproducibility values were high for CURE, SDI,
and Tmax SD. The average tracking error percentages of the
HARP analyses were similar in all patient groups (Table 2).
Discussion
The main findings of the study are as follows: (i) assessment of
intraventricular dyssynchrony validated in earlier animal studies
with LBBB could be transferred successfully into humans includ-
ing patients with LBBB and prior MI. (ii) Despite these different
underlying diseases, i.e. LBBB and ischaemic heart disease with
primarily antero-septal infarctions, the observed patterns of
dyssynchrony were similar between LBBB and antero-septal
MI. (iii) By utilization of a segmental-based dyssynchrony par-
ameter, viability information could be easily integrated to yield
a comprehensive map for dyssynchrony and viability assessment
in ischaemic heart disease, and (iv) a sufficiently high reproduci-
bility for these dyssynchrony parameters in patients was
demonstrated.
Figure 4 Linear regressions between scar mass as measured by
the late gadolinium enhancement technique and different dyssyn-
chrony and deformation parameters obtained from 3D tagging
data sets of MI patients. (A) Circumferential uniformity ratio esti-
mate. (B) systolic dyssynchrony index. (C) Mean csh(AVC) of the
entire LV. The plots demonstrate a positive relation between the
amount of scar and intraventricular dyssynchrony.
Figure 3 A high correlation was found between the circumfer-
ential uniformity ratio estimate (CURE) and the systolic dyssyn-
chrony index (SDI) parameter for the 70 subjects. The
correlation after elimination of the four patients to the far left
was similar as the original with y ¼ 2 4.6x + 4.8, r ¼ 0.92,
P, 0.0001). In controls CURE ranged from 0.97 to 1.0, for SDI
the range was 0.15–0.38.
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Figure 5 Representative 3D tagging results from a control (A–C), a left bundle branch block patient (D–F), and a myocardial infarction
patient (G–L). (A, D, G) Csh over the cardiac cycle for six segments on an equatorial level. (B, E, H) Bull’s eye plots of SDIsegm. (C, F, I) Short-
axis slice through the 3D tagging volumes at AVC with sector definitions. (J) Three representative slices of late gadolinium enhancement (LGE)
images out of 10 acquired slices are shown. (K) Bull’s eye plot for SDIviable is shown, where segments with scar mass  50% are excluded.
(L) Bull’s eye plot of viability as derived from LGE data. Shades of red represent degree of scar transmurality. For explanation of results,
see results section in the text.
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Transfer of a dyssynchrony cardiac
magnetic resonance technique into
patients with various underlying cardiac
pathologies
Current state-of-the-art imaging technology opens a wide spec-
trum of potential parameters to describe intraventricular dyssyn-
chrony. The CURE was evaluated in several animal studies with
LBBB to estimate LV dyssynchrony in longitudinal and circumfer-
ential directions.12 Circumferential uniformity ratio estimate
proved superior to other tagging parameters to identify the syn-
chronizing effect of various pacing modes.12,25 As a 3D data set
would ideally provide the basis for such analyses, a novel 3D
tagging strategy opened new perspectives by transferring the
technique into humans. Other tagging techniques required
45 min to cover the entire LV,26 whereas the present technique
acquires the complete data set in three breath-holds of 18 heart-
beats duration each. The technique produced adequate data
quality for analysis in 98.6% of all cases. Furthermore, the
HARP approach,27 modified to increase signal-to-noise ratio15
and thus to increase robustness of the analysis, produced
results in a few minutes, which is an important aspect of
imaging techniques, if applications in clinical practice are
anticipated.
Accurate and reproducible tests are of paramount importance
to better understand the mechanisms of action, e.g. of CRT, in
various forms of dyssynchrony. Reproducibility is also important
to reliably select possible candidates for CRT. In this context, it
is noteworthy that in the PROSPECT trial,9 a large multicenter
echo-based CRT trial, relevant conclusions were difficult to
draw, since the imaging parameters used to quantify dyssyn-
chrony were compromised by low reproducibility. In this
respect, the presented 3D tagging CMR approach fulfils several
requirements for successful clinical trials such as a short-
acquisition time, adequate robustness to be performed in
patients, fast semi-automatic analysis, and adequate
reproducibility.
Patterns of dyssynchrony in left bundle
branch block and ischaemic heart disease
Several dyssynchrony parameters such as the CURE parameter
were validated primarily in animals, and often the presence of an
LBBB was used as the model mimicking dyssynchrony.18,20
Although most dyssynchrony parameters are aimed at ‘condensing’
the dyssynchrony information into a single quantitative measure,
this approach is inherently limited by eliminating some information
on the local distribution of dyssynchrony. Therefore, in addition to
the CURE index, a dyssynchrony parameter was applied, which
measures systolic performance in each LV segment to preserve
spatial information, and then allows ‘condensing’ it into a single
value by calculating the statistical variability of the performance
in the various segments. The resulting SDI showed a similar
pattern for dyssynchrony as the CURE index (Figure 2), with
highest dyssynchrony in LBBB patients with reduced EF and a
dependency of dyssynchrony on the amount of scar tissue in MI
patients (Figure 4). The high variability of both SDI and CURE in
PatsLBBB could indeed reflect differences in dyssynchrony among
patients with LBBB. Animal studies in LBBB demonstrated substan-
tial differences in adaptive remodelling of hearts subjected to
LBBB,3 which could also cause differences in dyssynchrony, even
when evoked by the same conduction disturbance, i.e. LBBB.
Relationship between QRS duration
and cardiac magnetic resonance
dyssynchrony parameters
QRS duration of  120 ms is a major criterion among others to
select patients for CRT combining into a class I indication.6 In
this study, QRS duration showed a weak inverse relationship
with EF indicating that LV dyssynchrony, which goes along with
intraventricular unloading phenomena1,2 may be a reason among
others to reduce EF and thus, LV pumping efficiency. In the patients
with reduced EF after MI or with LBBB, the proposed SDIviable par-
ameter correlated weakly with QRS duration, whereas SDI and
CURE did not. This finding may provide indirect evidence, why
Figure 6 Bull’s eye plots of systolic dyssynchrony index averaged over each study group. For the patients with a medium-sized scar in the
antero-septal wall (15–25% of LV mass), a similar dyssynchrony pattern is observed as for the left bundle branch block patients.
A.K. Rutz et al.2124
QRS duration is adding valuable information to select patients
for CRT.
Integration of viability information into
a comprehensive approach to assess
dyssynchrony
The similarity of dyssynchrony patterns in LBBB and antero-septal
infarcts emphasize the importance of integrating viability infor-
mation into maps of dyssynchrony. The proposed SDI as any
segmental-based approach to quantify dyssynchrony is ideal to
integrate viability information. Assuming that a  50% scar trans-
murality in a given segment would prevent systolic contractions,
such segments can easily be eliminated from the calculation of a
global dyssynchrony estimate. For example, in the patient after
MI given in Figure 5, the SDIviable was 0.33, which is comparable
to the SDIviable of 0.27 obtained in the healthy control (95% con-
fidence interval of controls: 0.12–0.40). Consequently, the dyssyn-
chrony parameter SDIviable in this patient after MI would indicate
little or no potential improvement in contractile segmental func-
tion with pacing. Although a low SDIviable would indicate little
chance to benefit from CRT, future outcome studies will be
Figure 7 Inter-study (upper row), inter-observer (centre row), and intra-observer reproducibility (lower row) of parameters measuring left
ventricular dyssynchrony represented as Bland–Altman plots. Dashed horizontal lines indicate+ 95% limits of agreement, bold lines represent
mean differences (equal to bias). Since the sample sizes for these reproducibility measurements were rather small, the 95% confidence intervals
(grey lines) for the limits of agreement (dashed lines) are also given. The upper and lower limits of agreement for inter-study-circumferential
uniformity ratio estimate (CURE) are: 1.5–2.5% and 21.6% to 22.5%, respectively, for inter-study-systolic dyssynchrony index (SDI): 10.1–
18.5% and 226.1 to 217.7%, respectively, for inter-study-Tmax SD: 7.0–12.2% and 215.5% to 210.3%, respectively. For inter-observer-CURE:
3.5–6.9% and 28.0% to 24.6%, respectively; for inter-observer-SDI: 10.5–21.8% and 227.6% to 216.3%, respectively; for
inter-observer-Tmax SD: 8.9–19.2% and 226.0% to 215.7%, respectively. For intra-observer-CURE: 2.1–4.3% and 25.1% to 23.0%, respect-
ively; for intra-observer-SDI: 18.5–34.4% and 235.5% to 219.4%, respectively; for intra-observer-Tmax SD: 11.0–18.3% and 213.6% to
26.3%, respectively.
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needed to show whether a high SDIviable can predict responsive-
ness to CRT. It should be mentioned that any threshold of scar
transmurality can be applied to calculate and plot SDIviable. In par-
ticular, not only scar transmurality, but also absolute thickness of
scar and viable rim tissue are likely to determine responsiveness
to pacing. To further increase the likelihood to predict responsive-
ness to CRT, the proposed bull’s eye plot of SDIviable could also be
overlayed with an MR angiogram of the venous system for optimal
planning of the pacing site.
Limitations
The CURE index is well validated in LBBB in animal models. There-
fore, it was used in the present study as the reference for compari-
sons with other parameters of dyssynchrony such as the SDI. This
means that no other ‘gold standard’ for quantification of dyssyn-
chrony was applied in this study for the LBBB patients. Similarly,
for the PatsMI, no other measures of reference for dyssynchrony
were performed which is mainly explained by the lack of any absol-
utely established measure to quantify dyssynchrony in these
patients.
The 3D nature of the tagging data in the patients would allow for
a multi-directional analysis of strain in the LV, i.e. not only in cir-
cumferential, but also in longitudinal and radial directions.
However, previous data indicate that longitudinal strain is less sen-
sitive to dyssynchrony than circumferential strain.12
In the PatsMI group, there is a relatively large portion of antero-
septal infarcts, which limits the applicability of the study findings to
the overall post-MI population. This disproportion towards larger
antero-septal infarcts may be due to a higher rate of symptomatic
patients with these infarcts, which consequently may lead to a
higher rate of referrals for invasive diagnostics and treatment.
Assuming that scar tissue would not benefit from pacing, the
antero-septal infarcts are then an important model to demon-
strate, that these patients show a similar dyssynchrony pattern as
in LBBB, which is, however, readily discernable by a comprehensive
assessment of viability, i.e. by measuring SDIviable.
Conclusions
Dyssynchrony patterns due to LBBB or scar formation in the LV
were quantified by 3D-tagging CMR yielding global and segmental
dyssynchrony parameters. The proposed segmental dyssynchrony
approach also allowed integrating viability information resulting in
SDIviable, which quantifies dyssynchrony in viable tissue only.
Despite similar dyssynchrony patterns in LBBB and patients with
antero-septal MI, SDIviable unambiguously discriminated these
patient populations. Future studies are warranted to test the
value of such an integrated dyssynchrony—viability approach to
predict responsiveness to resynchronization.
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Appendix
Calculation of the cure index
Csh was plotted vs. spatial position for each slice and in each time
frame. The plots were subjected to Fourier analysis, and CURE was
calculated as follows: CURE ¼ (A02/[A02 + 2A12])1/2, where A02 and A12
are the sums over space and time of the zero and first-order
power terms, respectively. Thus, CURE represents a measure for
the amount of oscillation in the plots of csh vs. spatial position. Cir-
cumferential uniformity ratio estimate ranged from 0 (pure dyssyn-
chrony) to 1 (synchronous).
Calculation of the systolic
dyssynchrony index
The regional estimate in each segment (SDIsegm) was defined as the





Measuring the area under curve is less susceptible to noise than
analysing a single time point during contraction only.
The SD of the obtained values of all segments over the LV






The HARP tracking performance was determined by counting the
number of tracking errors during the HARP post-processing of
each data set. A tracking error of a material point from one time
frame to the next could be caused by the following reasons:14 (i)
non-convergence of the HARP algorithm; (ii) the displacement
exceeded the tagging distance; (iii) the displacement of neighbour-
ing points was significantly different. Tracking errors were detected
automatically and corrected by the software based on the motion
of correctly identified neighbouring points.
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